Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Partial least squares proportional hazard regression for application to DNA microarray survival data.

Danh V Nguyen1, David M Rocke

  • 1Department of Statistics, Texas A&M University, College Station, TX 77843, USA. dnguyen@stat.tamu.edu

Bioinformatics (Oxford, England)
|December 20, 2002
PubMed
Summary

Predicting cancer patient survival using gene expression data is crucial. This study introduces a novel method using partial least squares with proportional hazard regression to accurately predict survival times, even with high-dimensional data.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nondialytic Care vs Dialysis Transition on Hospitalization: Outcomes in Veterans With Advanced Chronic Kidney Disease.

Mayo Clinic proceedings·2026
Same author

Continuous Glucose Monitoring and Mortality Risk Among U.S. Veterans Receiving Dialysis With Diabetes.

Diabetes care·2026
Same author

A pilot study of neuropsychological testing in a civilian traumatic brain injury clinic: Neurocognitive profiles, temporal trends and cognitive screening.

Applied neuropsychology. Adult·2026
Same author

Effects of Extracorporeal Life Support Volume on Neonatal Mortality in Congenital Diaphragmatic Hernia: A Retrospective Cohort Study.

The Journal of pediatrics·2026
Same author

Continuous glucose monitoring in patients with chronic kidney disease on dialysis and with kidney transplantation.

Current opinion in nephrology and hypertension·2026
Same author

Dietary potassium and fiber intake, survival, and health-related quality of life, in a prospective multi-center hemodialysis cohort.

Clinical nutrition (Edinburgh, Scotland)·2026

Area of Science:

  • Bioinformatics
  • Cancer Research
  • Statistical Genetics

Background:

  • Microarrays are widely used in cancer research for gene transcription analysis.
  • Integrating gene expression data with patient survival information is key for predictive modeling.
  • Traditional proportional hazard (PH) regression models struggle with high-dimensional data where covariates (p) exceed samples (N).

Purpose of the Study:

  • To develop and demonstrate a method for predicting patient survival times from high-dimensional gene expression data.
  • To address the challenge of N << p in survival analysis using microarray data.
  • To apply partial least squares (PLS) for dimension reduction in gene expression-based survival prediction.

Main Methods:

  • Utilized partial least squares (PLS) for dimension reduction, employing survival times as the response variable.

Related Experiment Videos

  • Extracted PLS gene components to serve as covariates in a proportional hazard (PH) regression model.
  • Applied the methodology to two distinct cDNA gene expression datasets with associated survival data.

    • Main Results:

    • Successfully demonstrated a method for predicting survival probabilities in high-dimensional gene expression settings (N << p).
    • The PLS-enhanced PH regression effectively predicted survival outcomes using reduced gene components.
    • Validated the approach on datasets from diffuse large B-cell lymphoma (DLBCL) and locally advanced breast cancer patients.

    Conclusions:

    • The proposed dimension reduction technique using PLS is effective for survival prediction with high-dimensional gene expression data.
    • This approach offers a viable solution for analyzing microarray data in cancer survival studies.
    • The methodology shows promise for improving prognostic accuracy in cancer patient populations.